Use of erythropoietin and its effects on blood lactate and 2,3-diphosphoglycerate in premature neonates

Biology of the Neonate

Volumn 78, Issue 4, 2000, Pages 281-287

  Soubasi, Vassiliki ^a   Kremenopoulos, George ^a   Tsantali, Chaido ^a   Savopoulou, Persefoni ^a   Mussafiris, Constantine ^a   Dimitriou, Maria ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

2,3 DPG; Anaemia of prematurity; Erythropoietin; Lactate

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ALPHA TOCOPHEROL; FOLIC ACID; HEMOGLOBIN F; IRON; LACTIC ACID; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD CELL COUNT; BLOOD GAS ANALYSIS; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; IRON THERAPY; LACTATE BLOOD LEVEL; NEWBORN; OXYGEN AFFINITY; OXYGEN DISSOCIATION CURVE; OXYGEN TRANSPORT; PREMATURITY; PRIORITY JOURNAL; VERY LOW BIRTH WEIGHT; VITAMIN SUPPLEMENTATION;

OXY;

EID: 0033646519     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014280     Document Type: Article

References (32)

1. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very low birth-weight infants
2. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants
3. Recombinant human erythropoietin in the treatment of the anemia of prematurity: Results of a double-blind, placebo-controlled study
4. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants
5. Erythropoietin, protein, and iron supplementation and the prevention of anemia of prematurity
6. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized controlled study
7. The best timing of recombinant human erythropoietin administration of prematurity: A randomized controlled study
8. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity
9. Transfusion practices in infants receiving assisted ventilation
10. Recombinant human erythropoietin treatment for anemia of prematurity on standard or high-dose iron supplementation
11. Lactate pyruvate and ketone bodies in techniques in diagnostic
12. Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain
13. Induction of fetal hemoglobin by EPO ginen in preterm neonates for the prevention of anemia of prematurity
14. Lactic acid as a predictor for erythrocyte transfusion in healthy preterm infants with anemia of prematurity
15. The red cell, 2,3-diphosphoglycerate, and tissue oxygen release
16. The shift to the left
17. Postnatal changes in oxygen transport of term, premature, and sick infants: The role of red cell 2,3-diphosphoglycerate and adult hemoglobin
18. The regulation of oxygen affinity of fetal blood. I. In vitro experiments and results in normal infants
19. The relative effect of 2,3-diphosphoglycerate on the oxygen affinity of fetal and adult hemoglobin in whole blood
20. Oxygen transport and delivery
21. Developmental erythropoiesis
22. Lactate levels in anemic preterm infants
23. The physiologic impact of anemia of neonate
24. Haemoglobin is inversely related to plasma lactate and heart rate in the newborn piglet
25. A randomized trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age
26. Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity in infants with bronchopulmonary dysplasia
27. Do cardiac output and serum lactate levels indicate blood transfusion requirements in anemia of prematurity?
28. Perinatal changes of 2,3-diphosphoglycerate and oxygen affinity in mammals not having fetal type hemoglobins
29. Association between blood lactate and acid-base status and mortality in ventilated babies
30. Oxygen transport in congenital heart disease: Influence of fetal hemoglobin, red cell pH, and 2,3-diphosphoglycerate
31. Dual effect of 2,3-diphosphoglycerate on the Bohr effects of human blood
32. 2 50%, and available oxygen in young rabbits with and without postnatal fall in hemoglobin